BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fagiolini A, Florea I, Loft H, Christensen MC. Effectiveness of Vortioxetine on Emotional Blunting in Patients with Major Depressive Disorder with inadequate response to SSRI/SNRI treatment. J Affect Disord 2021;283:472-9. [PMID: 33516560 DOI: 10.1016/j.jad.2020.11.106] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Christensen MC, Fagiolini A, Florea I, Loft H, Cuomo A, Goodwin GM. Validation of the Oxford Depression Questionnaire: Sensitivity to change, minimal clinically important difference, and response threshold for the assessment of emotional blunting. J Affect Disord 2021;294:924-31. [PMID: 34378539 DOI: 10.1016/j.jad.2021.07.099] [Reference Citation Analysis]
2 Christensen MC, McIntyre RS, Florea I, Loft H, Fagiolini A. Vortioxetine 20 mg/day in patients with major depressive disorder: updated analysis of efficacy, safety, and optimal timing of dose adjustment. CNS Spectr 2021;:1-26. [PMID: 34657638 DOI: 10.1017/S1092852921000936] [Reference Citation Analysis]
3 De Diego-Adeliño J, Crespo JM, Mora F, Neyra A, Iborra P, Gutiérrez-Rojas L, Salonia SF. Vortioxetine in major depressive disorder: from mechanisms of action to clinical studies. An updated review. Expert Opin Drug Saf 2021;:1-18. [PMID: 34964415 DOI: 10.1080/14740338.2022.2019705] [Reference Citation Analysis]
4 Ma H, Cai M, Wang H. Emotional Blunting in Patients With Major Depressive Disorder: A Brief Non-systematic Review of Current Research. Front Psychiatry 2021;12:792960. [PMID: 34970173 DOI: 10.3389/fpsyt.2021.792960] [Reference Citation Analysis]
5 Zheng W, Gu LM, Sun CH, Zhou YL, Wang CY, Lan XF, Zhang B, Ning YP. Comparative effectiveness of repeated ketamine infusions in treating anhedonia in bipolar and unipolar depression. J Affect Disord 2021;300:109-13. [PMID: 34965393 DOI: 10.1016/j.jad.2021.12.105] [Reference Citation Analysis]